-
1
-
-
84940815279
-
The physiological activity of adenine compounds with special reference to their action upon the mammalian heart
-
DRURY AN, SZENT-GYÖRGYI A: The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol. (1929) 68:213-237.
-
(1929)
J. Physiol.
, vol.68
, pp. 213-237
-
-
Drury, A.N.1
Szent-Györgyi, A.2
-
3
-
-
0028796899
-
Neurotransmitter receptors VII: Adenosine receptors
-
PALMER TM, STILES GL: Neurotransmitter receptors VII: adenosine receptors. Neuropharmacology (1995) 7:683-694.
-
(1995)
Neuropharmacology
, vol.7
, pp. 683-694
-
-
Palmer, T.M.1
Stiles, G.L.2
-
4
-
-
0031593681
-
3 receptors: Novel ligands and paradoxical effects
-
JACOBSON KA: Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci. (1998) 19:184-191.
-
(1998)
Trends Pharmacol. Sci.
, vol.19
, pp. 184-191
-
-
Jacobson, K.A.1
-
5
-
-
0030847083
-
Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology
-
SHRYOCK JC, BELARDINELLI L: Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. (1997) 79:2-10.
-
(1997)
Am. J. Cardiol.
, vol.79
, pp. 2-10
-
-
Shryock, J.C.1
Belardinelli, L.2
-
6
-
-
0031833150
-
Adenosine receptors: New opportunities for future drugs
-
POULSEN S-A, QUINN RJ: Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. (1998) 6:619-641.
-
(1998)
Bioorg. Med. Chem.
, vol.6
, pp. 619-641
-
-
Poulsen, S.-A.1
Quinn, R.J.2
-
7
-
-
0025349998
-
2 receptors that promote chemotaxis and inhibit O2-generation, respectively
-
CRONSTEIN BN, DAGUMA L, NICHOLS D, HUTCHINSON AJ, WILLIAMS M: The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2-generation, respectively. J. Clin. Invest. (1990) 85:1150-1157.
-
(1990)
J. Clin. Invest.
, vol.85
, pp. 1150-1157
-
-
Cronstein, B.N.1
Daguma, L.2
Nichols, D.3
Hutchinson, A.J.4
Williams, M.5
-
8
-
-
0030614436
-
2 receptor activation attenuates reperfu-sion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence
-
JORDAN JE, ZHAO Z, SATO H, VINTEN-JOHANSEN J: Adenosine A2 receptor activation attenuates reperfu-sion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J. Pharmacol. Exp. Ther. (1997) 280:301-309.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.280
, pp. 301-309
-
-
Jordan, J.E.1
Zhao, Z.2
Sato, H.3
Vinten-Johansen, J.4
-
9
-
-
0017848013
-
Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactiva-tion on lipolysis in rat fat cells
-
FREDHOLM BB: Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactiva-tion on lipolysis in rat fat cells. Acta Physiol. Scand. (1978) 102:191-198.
-
(1978)
Acta Physiol. Scand.
, vol.102
, pp. 191-198
-
-
Fredholm, B.B.1
-
10
-
-
0027318715
-
Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236
-
STRONG P, ANDERSON R, COATES J et al.: Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236. Clin. Sci. (1993) 84:663-669.
-
(1993)
Clin. Sci.
, vol.84
, pp. 663-669
-
-
Strong, P.1
Anderson, R.2
Coates, J.3
-
11
-
-
0018332228
-
6-disubst-ituted adenosine derivative (B.M. 11.189) on fat cell metabolism
-
WIESER PB, PENDLETON TS: Effects of an N6-disubst-ituted adenosine derivative (B.M. 11.189) on fat cell metabolism. Biochem. Pharmacol. (1979) 28:693-694.
-
(1979)
Biochem. Pharmacol.
, vol.28
, pp. 693-694
-
-
Wieser, P.B.1
Pendleton, T.S.2
-
13
-
-
0014666301
-
Increased plasma-free-fatty acid concentrations and their significance in patients with acute myocardial infarction
-
GUPTA DK, JEWITT DE, YOUNG R, HARTOG M, OPIE LH: Increased plasma-free-fatty acid concentrations and their significance in patients with acute myocardial infarction. Lancet (1969) 2:1209-1213.
-
(1969)
Lancet
, vol.2
, pp. 1209-1213
-
-
Gupta, D.K.1
Jewitt, D.E.2
Young, R.3
Hartog, M.4
Opie, L.H.5
-
14
-
-
0029068815
-
Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge?
-
VAN DE WERF, F: Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge? Circulation (1995) 91:2862-2864.
-
(1995)
Circulation
, vol.91
, pp. 2862-2864
-
-
Van De Werf, F.1
-
15
-
-
0029119037
-
99mTc sestamibi imaging predicts subsequent mortality
-
MILLER TD, CHRISTIAN TF, HOPFENSPIRGER MR, HODGES RO, GERSH BJ, GIBBONS RJ: Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation (1995) 92:334-341.
-
(1995)
Circulation
, vol.92
, pp. 334-341
-
-
Miller, T.D.1
Christian, T.F.2
Hopfenspirger, M.R.3
Hodges, R.O.4
Gersh, B.J.5
Gibbons, R.J.6
-
16
-
-
0028929031
-
Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction
-
CHAREONTHAITAWEE P, CHRISTIAN TF, HIROSE K, GIBBONS RJ, RUMBERGER JA: Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J. Am. Coll. Cardiol. (1995) 25:567-573.
-
(1995)
J. Am. Coll. Cardiol.
, vol.25
, pp. 567-573
-
-
Chareonthaitawee, P.1
Christian, T.F.2
Hirose, K.3
Gibbons, R.J.4
Rumberger, J.A.5
-
17
-
-
0031856855
-
Adjunctive therapy after reperfusion therapy in acute myocardial infarction
-
DRIES DL, SOLOMON AJ, GERSH BJ: Adjunctive therapy after reperfusion therapy in acute myocardial infarction. Clin. Cardiol. (1998) 21:379-386.
-
(1998)
Clin. Cardiol.
, vol.21
, pp. 379-386
-
-
Dries, D.L.1
Solomon, A.J.2
Gersh, B.J.3
-
18
-
-
0030869951
-
Adjunctive therapy for acute myocardial infarction
-
ALEXANDER J: Adjunctive therapy for acute myocardial infarction. Curr. Opin. Cardiol. (1997) 12:453-458.
-
(1997)
Curr. Opin. Cardiol.
, vol.12
, pp. 453-458
-
-
Alexander, J.1
-
19
-
-
0029024202
-
Myocardial reperfusion injury: Experimental evidence and clinical relevance
-
HANSEN PR: Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur. Heart J. (1995) 16:734-740.
-
(1995)
Eur. Heart J.
, vol.16
, pp. 734-740
-
-
Hansen, P.R.1
-
20
-
-
0025944674
-
Reperfusion induced injury. Manifestations, mechanisms and clinical relevance
-
HEARSE DJ, BOLLI R: Reperfusion induced injury. Manifestations, mechanisms and clinical relevance. Trends Cardiovasc. Med. (1991) 1:233-240.
-
(1991)
Trends Cardiovasc. Med.
, vol.1
, pp. 233-240
-
-
Hearse, D.J.1
Bolli, R.2
-
21
-
-
0028946762
-
Physiologic mechanisms of postischemic tissue injury
-
GRANGER DN, KORTHUIS RJ: Physiologic mechanisms of postischemic tissue injury. Ann. Rev. Physiol. (1995) 57:311-332.
-
(1995)
Ann. Rev. Physiol.
, vol.57
, pp. 311-332
-
-
Granger, D.N.1
Korthuis, R.J.2
-
22
-
-
0028883828
-
Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia
-
SHEPHERD J, COBBE ASM, FORD et al.: Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia. N. Engl. J. Med. (1995) 333:1301-1307.
-
(1995)
N. Engl. J. Med.
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Asm, C.2
Ford3
-
23
-
-
0027987849
-
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin survival study
-
SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP
-
SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study. Lancet (1994) 344:1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
24
-
-
0002746856
-
Serum triglycerides in coronary artery disease
-
ALBRINK M, MAN EB: Serum triglycerides in coronary artery disease. Arch. Int. Med. (1959) 103:4-8.
-
(1959)
Arch. Int. Med.
, vol.103
, pp. 4-8
-
-
Albrink, M.1
Man, E.B.2
-
25
-
-
0001630654
-
Serum triglycerides in health and in ischemic heart disease
-
BROWN DF, KINCH SH, DOYLE JT: Serum triglycerides in health and in ischemic heart disease. N. Engl. J. Med. (1965) 273:947-952.
-
(1965)
N. Engl. J. Med.
, vol.273
, pp. 947-952
-
-
Brown, D.F.1
Kinch, S.H.2
Doyle, J.T.3
-
26
-
-
0033551386
-
Epidemiology of hypertriglyceridemia and cardiovascular disease
-
AUSTIN MA: Epidemiology of hypertriglyceridemia and cardiovascular disease. Am. J. Cardiol. (1999) 83:13F-16F.
-
(1999)
Am. J. Cardiol.
, vol.83
-
-
Austin, M.A.1
-
27
-
-
0033056375
-
Treating patients with hypertriglyc-eridemia saves lives: Triglyceride revisited
-
MOONEY A: Treating patients with hypertriglyc-eridemia saves lives: triglyceride revisited. Curr. Med. Res. Opin. (1999) 15:65-77.
-
(1999)
Curr. Med. Res. Opin.
, vol.15
, pp. 65-77
-
-
Mooney, A.1
-
28
-
-
0345620788
-
Hypertriglyceridemia: Changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease
-
BREWER HB: Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am. J. Cardiol. (1999) 83:3F-12F.
-
(1999)
Am. J. Cardiol.
, vol.83
-
-
Brewer, H.B.1
-
29
-
-
0029618375
-
Linking research strategies to market opportunities for new cardiovascular drugs
-
MAGGON KK: Linking research strategies to market opportunities for new cardiovascular drugs. Drugs News Perspect. (1995) 8:560-571.
-
(1995)
Drugs News Perspect.
, vol.8
, pp. 560-571
-
-
Maggon, K.K.1
-
30
-
-
0029804941
-
ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
-
RYAN TJ, ANDERSON JL: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation (1996) 94:2341-2350.
-
(1996)
Circulation
, vol.94
, pp. 2341-2350
-
-
Ryan, T.J.1
Anderson, J.L.2
-
32
-
-
0030848709
-
Phenotype expression in familial combined hyperlipidemia
-
PORKKA KVK, NUOTIO I, PAJUKANTA et al.: Phenotype expression in familial combined hyperlipidemia. Atherosclerosis (1997) 133:245-253.
-
(1997)
Atherosclerosis
, vol.133
, pp. 245-253
-
-
Porkka, K.V.K.1
Nuotio, I.2
Pajukant, A.3
-
33
-
-
0032562257
-
Triglyeride concentration and ischemic heart disease: An eight year follow-upinthe Copenhagen male study
-
JEPPESEN J, HEIN HO, SUADICANI P, GYNTELBERG F: Triglyeride concentration and ischemic heart disease: an eight year follow-upinthe Copenhagen male study. Circulation (1998) 97:1029-1036.
-
(1998)
Circulation
, vol.97
, pp. 1029-1036
-
-
Jeppesen, J.1
Hein, H.O.2
Suadicani, P.3
Gyntelberg, F.4
-
34
-
-
0032080923
-
Normal triglyceride levels and coronary artery disease events: The baltimore coronary observational long-term study
-
MILLER M, SEIDLER A, MOALEMI A, PEARSON TA: Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J. Am. Coll. Cardiol. (1998) 31:1252-1257.
-
(1998)
J. Am. Coll. Cardiol.
, vol.31
, pp. 1252-1257
-
-
Miller, M.1
Seidler, A.2
Moalemi, A.3
Pearson, T.A.4
-
35
-
-
0022970945
-
Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
-
MURRY CE, JENNINGS RB, REIMER KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 74:1124-1136.
-
(1986)
Circulation
, vol.74
, pp. 1124-1136
-
-
Murry, C.E.1
Jennings, R.B.2
Reimer, K.A.3
-
36
-
-
0027297849
-
ATP channels, and ischemic preconditioning in dogs
-
AUCHAMPACH JA, GROSS GJ: Adenosine A1 receptor, KATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. (1993) 264:H1327-H1336
-
(1993)
Am. J. Physiol.
, vol.264
-
-
Auchampach, J.A.1
Gross, G.J.2
-
37
-
-
0026700067
-
Ischemic preconditioning: Nature's own cardioprotective mechanism
-
DOWNEY JM: Ischemic preconditioning: Nature's own cardioprotective mechanism. Trends Cardiovasc. Med. (1992) 2:170-176.
-
(1992)
Trends Cardiovasc. Med.
, vol.2
, pp. 170-176
-
-
Downey, J.M.1
-
38
-
-
0029058094
-
Involvement of endogenous adenosine in ischaemic preconditioning in swine
-
SCHULZ R, ROSE J, POST H, HEUSCH G: Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch. (1995) 430:273-282.
-
(1995)
Pflugers Arch.
, vol.430
, pp. 273-282
-
-
Schulz, R.1
Rose, J.2
Post, H.3
Heusch, G.4
-
39
-
-
0032900356
-
1-receptor agonist, in myocar-dial ischaemia-reperfusion injury in the pig
-
LOUTTIT JB, HUNT AAE, MAXWELL MP, DREW GM: The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocar-dial ischaemia-reperfusion injury in the pig. J. Cardio-vasc. Pharmacol. (1999) 33:285-291.
-
(1999)
J. Cardio-vasc. Pharmacol.
, vol.33
, pp. 285-291
-
-
Louttit, J.B.1
Aae, H.2
Maxwell, M.P.3
Drew, G.M.4
-
40
-
-
0026548414
-
2-receptor agonistsonmyocardial reperfusion injury
-
NORTON ED, JACKSON EK, TURNER MB, VIRMANI R, FORMAN MB: The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonistsonmyocardial reperfusion injury. Am. Heart J. (1992) 123:332-338.
-
(1992)
Am. Heart J.
, vol.123
, pp. 332-338
-
-
Norton, E.D.1
Jackson, E.K.2
Turner, M.B.3
Virmani, R.4
Forman, M.B.5
-
41
-
-
0027336240
-
2 receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart
-
SCHLACK W, SCHÄFER M, UEBING A, SCHÄFER S, BORCHARD U, THÄMER V: Adenosine A2 receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J. Cardiovasc. Pharmacol. (1993) 22:89-96.
-
(1993)
J. Cardiovasc. Pharmacol.
, vol.22
, pp. 89-96
-
-
Schlack, W.1
Schäfer, M.2
Uebing, A.3
Schäfer, S.4
Borchard, U.5
Thämer, V.6
-
42
-
-
0032499689
-
3 receptor: Sustained cardioprotection
-
LIANG BT, JACOBSON KA: A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc. Natl. Acad. Sci. USA (1998) 95:6995-6999.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 6995-6999
-
-
Liang, B.T.1
Jacobson, K.A.2
-
43
-
-
0030615054
-
3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart
-
TRACEY WR, MAGEE W, MASAMUNE H et al.: Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc. Res. (1997) 33:410-415.
-
(1997)
Cardiovasc. Res.
, vol.33
, pp. 410-415
-
-
Tracey, W.R.1
Magee, W.2
Masamune, H.3
-
44
-
-
0028849820
-
Cardiovascular and antilipolytic effects of the adenosine agonist GR79236
-
MERKEL LA, HAWKINS ED, COLUSSI DJ et al.: Cardiovascular and antilipolytic effects of the adenosine agonist GR79236. Pharmacology (1995) 51:224-236.
-
(1995)
Pharmacology
, vol.51
, pp. 224-236
-
-
Merkel, L.A.1
Hawkins, E.D.2
Colussi, D.J.3
-
45
-
-
0028906835
-
General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist
-
WAGNER H, MILAVEC-KRIZMAN M, GADIENT F et al.: General pharmacology of SDZ WAG 994, a potent selective and orally active adenosine A1 receptor agonist. Drug Dev. Res. (1995) 34:276-288.
-
(1995)
Drug Dev. Res.
, vol.34
, pp. 276-288
-
-
Wagner, H.1
Milavec-Krizman, M.2
Gadient, F.3
-
46
-
-
0027358825
-
In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202
-
MERKEL LA, RIVERA LM, COLUSSI DJ, PERRONE MH, SMITS GJ, COX BF: In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202. J. Pharmacol. Exp. Ther. (1993) 265:699-706.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.265
, pp. 699-706
-
-
Merkel, L.A.1
Rivera, L.M.2
Colussi, D.J.3
Perrone, M.H.4
Smits, G.J.5
Cox, B.F.6
-
47
-
-
0032444747
-
2 receptor agonist and cardioprotective
-
MERKEL L, ROJAS CJ, JARVIS MF et al.: Pharmacological characterization of AMP 579, A novel adenosine A1/A2 receptor agonist and cardioprotective. Drug Dev. Res. (1998) 45:30-43.
-
(1998)
Drug Dev. Res.
, vol.45
, pp. 30-43
-
-
Merkel, L.1
Rojas, C.J.2
Jarvis, M.F.3
-
48
-
-
0022908516
-
Suppression of free fatty acids and triglyc-erides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladeno-sine
-
HOFFMAN B, DALL'AGLIO E, HOLLENBECK C, CHANG H, REAVEN G: Suppression of free fatty acids and triglyc-erides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladeno-sine. J. Pharmacol. Exp. Ther. (1986) 239:715-718.
-
(1986)
J. Pharmacol. Exp. Ther.
, vol.239
, pp. 715-718
-
-
Hoffman, B.1
Dall'Aglio, E.2
Hollenbeck, C.3
Chang, H.4
Reaven, G.5
-
49
-
-
0032542388
-
Effect of niacin on atherosclerotic cardiovascular disease
-
GUYTON JR: Effect of niacin on atherosclerotic cardiovascular disease. Am. J. Cardiol. (1998) 82:18U-23U.
-
(1998)
Am. J. Cardiol.
, vol.82
-
-
Guyton, J.R.1
-
50
-
-
0000759802
-
Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial
-
MAHAFFEY KW, PUMA JA, BARBAGELATA A et al.: Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial. Circulation (1997) 96 (S1):206-207.
-
(1997)
Circulation
, vol.96
, Issue.S1
, pp. 206-207
-
-
Mahaffey, K.W.1
Puma, J.A.2
Barbagelata, A.3
-
51
-
-
0030740126
-
Role of adenosine in the cardiac catheteri-zation laboratory
-
OGILBY JD: Role of adenosine in the cardiac catheteri-zation laboratory. Am. J. Cardiol. (1997) 79:15-19.
-
(1997)
Am. J. Cardiol.
, vol.79
, pp. 15-19
-
-
Ogilby, J.D.1
-
52
-
-
0030795989
-
Myocardial perfusion imaging during adenosine-induced coronary hyperemia
-
ISKANDRIAN AE, JAEKYEONG H: Myocardial perfusion imaging during adenosine-induced coronary hyperemia. Am. J. Cardiol. (1997) 79:20-24.
-
(1997)
Am. J. Cardiol.
, vol.79
, pp. 20-24
-
-
Iskandrian, A.E.1
Jaekyeong, H.2
-
54
-
-
0030871604
-
Adenosine for myocardial protection in acute myocardial infarction
-
GRANGER CB: Adenosine for myocardial protection in acute myocardial infarction. Am. J. Cardiol. (1997) 79:44-48.
-
(1997)
Am. J. Cardiol.
, vol.79
, pp. 44-48
-
-
Granger, C.B.1
-
55
-
-
0031854292
-
Intravenous adenosine and lidocaine in patients with acute myocardial infarction
-
GARRATT KN, HOLMES DR, MOLINA-VIAMONTE V et al.: Intravenous adenosine and lidocaine in patients with acute myocardial infarction. Am. Heart J. (1998) 136:196-204.
-
(1998)
Am. Heart J.
, vol.136
, pp. 196-204
-
-
Garratt, K.N.1
Holmes, D.R.2
Molina-Viamonte, V.3
-
57
-
-
0030971672
-
Preconditioning of human myocardium with adenosine during coronary angioplasty
-
LEESAR MA, STODDARD M, AHMED M, BROADBENT J, BOLLI R: Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation (1997) 95:2500-2507.
-
(1997)
Circulation
, vol.95
, pp. 2500-2507
-
-
Leesar, M.A.1
Stoddard, M.2
Ahmed, M.3
Broadbent, J.4
Bolli, R.5
-
58
-
-
0032941838
-
2 receptor agonist, AMP 579; Coronary hemodynamic and cardioprotective activityin canine myocardium
-
MCVEY M, SMITS GJ, KITZEN J, CLARK KL, PERRONE MH: Cardiovascular pharmacology of the adenosine A1/A2 receptor agonist, AMP 579; coronary hemodynamic and cardioprotective activityin canine myocardium. J. Cardiovasc. Pharmacol. (1999) 33:703-710.
-
(1999)
J. Cardiovasc. Pharmacol.
, vol.33
, pp. 703-710
-
-
McVey, M.1
Smits, G.J.2
Kitzen, J.3
Clark, K.L.4
Perrone, M.H.5
-
59
-
-
0032423596
-
2 receptor agonist, AMP 579, in a porcine model of myocardial infarction
-
SMITS GJ, MCVEY M, COX BF, PERRONE MH, CLARK KL: Cardioprotective effects of the novel adenosine A1/A2 receptor agonist, AMP 579, in a porcine model of myocardial infarction. J. Pharmacol. Exp. Ther. (1998) 286:611-618.
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.286
, pp. 611-618
-
-
Smits, G.J.1
McVey, M.2
Cox, B.F.3
Perrone, M.H.4
Clark, K.L.5
-
60
-
-
0007298731
-
A novel adenosine analog AMP 579 inhibits neutrophil activation, adherence and neutrophil mediated injury to coronary vascular endothelium
-
NAKAMURA M, ZHAO Z, CLARK KL, GUYTON RA, VINTEN-JOHANSEN J: A novel adenosine analog AMP 579 inhibits neutrophil activation, adherence and neutrophil mediated injury to coronary vascular endothelium. Circulation (1998) 98:I-666.
-
(1998)
Circulation
, vol.98
-
-
Nakamura, M.1
Zhao, Z.2
Clark, K.L.3
Guyton, R.A.4
Vinten-Johansen, J.5
-
61
-
-
80052091286
-
AMP 579 induces prolonged protection against myocardial infarction in minipig
-
MENG H, McVEY M, PERRONE M, CLARK KL: AMP 579 induces prolonged protection against myocardial infarction in minipig. J. Mol. Cell Cardiol. (1999) 31:A12.
-
(1999)
J. Mol. Cell Cardiol.
, vol.31
-
-
Meng, H.1
McVey, M.2
Perrone, M.3
Clark, K.L.4
-
62
-
-
0033307237
-
Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers
-
ZANNIKOS PN, BAYBUTT RI, BOUTOUYRIE BX, SHAH B, HUNT TL, JENSEN BK: Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers. J. Clin. Pharmacol. (1999) 39:1-9.
-
(1999)
J. Clin. Pharmacol.
, vol.39
, pp. 1-9
-
-
Zannikos, P.N.1
Baybutt, R.I.2
Boutouyrie, B.X.3
Shah, B.4
Hunt, T.L.5
Jensen, B.K.6
-
63
-
-
0031021506
-
Effects of acadesine on myocardial infarction, stroke, and death following surgery
-
MANGANO DT: Effects of acadesine on myocardial infarction, stroke, and death following surgery. JAMA (1997) 277:325-333.
-
(1997)
JAMA
, vol.277
, pp. 325-333
-
-
Mangano, D.T.1
-
64
-
-
0032774426
-
The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusioninjury. from amiloridetocariporide
-
KARMAZYN M: The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusioninjury. From amiloridetocariporide.Ann. NY Acad. Sci. (1999) 874:326-334.
-
(1999)
Ann. NY Acad. Sci.
, vol.874
, pp. 326-334
-
-
Karmazyn, M.1
-
65
-
-
0031940890
-
Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury
-
ELLIOTT GT: Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury. J. Mol. Cell Cardiol. (1998) 30:3-17.
-
(1998)
J. Mol. Cell Cardiol.
, vol.30
, pp. 3-17
-
-
Elliott, G.T.1
-
66
-
-
9444258047
-
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction
-
SCHAER GL, SPACCAVENTO LJ, BROWNE KFet al.: Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation (1996) 94:298-307.
-
(1996)
Circulation
, vol.94
, pp. 298-307
-
-
Schaer, G.L.1
Spaccavento, L.J.2
Browne, K.F.3
-
67
-
-
0033031710
-
Effect of adenosine on heart rate variability in humans
-
RONGEN GA, BROOKS SC, POLLARD MJ et al.: Effect of adenosine on heart rate variability in humans. Clin. Sci. (1999) 96:597-604.
-
(1999)
Clin. Sci.
, vol.96
, pp. 597-604
-
-
Rongen, G.A.1
Brooks, S.C.2
Pollard, M.J.3
-
68
-
-
85047680481
-
1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischemia
-
ZHAO ZQ, NAKANISHI K, MCGEE DS, TAN P, VINTEN-JOHANSEN J: A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischemia. Cardiovasc. Res. (1994) 28:270-279.
-
(1994)
Cardiovasc. Res.
, vol.28
, pp. 270-279
-
-
Zhao, Z.Q.1
Nakanishi, K.2
McGee, D.S.3
Tan, P.4
Vinten-Johansen, J.5
-
69
-
-
0027264787
-
Functional characterization of three adenosine receptor subtypes
-
GURDEN MF, COATES J, ELLIS F et al.: Functional characterization of three adenosine receptor subtypes. Br. J. Pharmacol. (1993) 109:693-698.
-
(1993)
Br. J. Pharmacol.
, vol.109
, pp. 693-698
-
-
Gurden, M.F.1
Coates, J.2
Ellis, F.3
-
70
-
-
0030783720
-
1 receptor in vivo
-
VAN SCHAICK EA, MATHÔT RAA, GUBBNES-STIBBE JM et al.: 8-Alkylamino-substituted analogs of N6-cyclopent-yladenosine are partial agonists for the cardiovascular adenosine A1 receptor in vivo. J. Pharmacol. Exp. Ther. (1997b) 283:800-808.
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.283
, pp. 800-808
-
-
Van Schaick, E.A.1
Raa, M.2
Gubbnes-Stibbe, J.M.3
-
71
-
-
0030962760
-
6-(p-sulfophenyl) adenosine in the rat
-
VAN SCHAICK EA, DE GREEF HJMM, LANGEMEIJER MWE, SHEEHAN MJ, IJZERMAN AP, DANHOF M: Pharmacoki-netic-pharmacodynamic modeling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulfophenyl) adenosine in the rat. Br. J. Pharmacol. (1997a) 122:525-533.
-
(1997)
Br. J. Pharmacol.
, vol.122
, pp. 525-533
-
-
Van Schaick, E.A.1
De Greef, H.J.M.M.2
Langemeijer, M.W.E.3
Sheehan, M.J.4
Ijzerman, A.P.5
Danhof, M.6
-
72
-
-
0028239364
-
The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat
-
GARDNER CJ, TWISSELL DJ, COATES J, STRONG P: The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat. Eur. J. Pharmacol. (1994) 257:117-121.
-
(1994)
Eur. J. Pharmacol.
, vol.257
, pp. 117-121
-
-
Gardner, C.J.1
Twissell, D.J.2
Coates, J.3
Strong, P.4
-
73
-
-
0032789519
-
1 receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo
-
VAN DER GRAAF PH, VAN SCHAICK EA, VISSER SAG, DE GREEF HJMM, IJZERMAN AP, DANHOF M: Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A1 receptor agonists in rats: prediction of tissue-dependent efficacy in vivo. J. Pharmacol. Exp. Ther. (1999) 290:702-709.
-
(1999)
J. Pharmacol. Exp. Ther.
, vol.290
, pp. 702-709
-
-
Van Der Graaf, P.H.1
Van Schaick, E.A.2
Visser, S.A.G.3
De Greef, H.J.M.M.4
Ijzerman, A.P.5
Danhof, M.6
-
74
-
-
17544383117
-
Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors
-
PALMER TM, BENOVIC JL, STILES GL: Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. J. Biol. Chem. (1996) 271:15272-15278.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 15272-15278
-
-
Palmer, T.M.1
Benovic, J.L.2
Stiles, G.L.3
|